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disease in Russia (http://clinical-pharmacy.ru). The most com-
mon approaches to control melanoma are surgical resection,
chemotherapy, radiotherapy, and immunotherapy (Wildemore
et al., 2001). In the case of immunotherapy interferon prepara-
tions are the most commonly used, however, it is impossible to
increase overall survival rate. Vaccine therapy is more promising
method including engineered DNA-vaccines. The goal of this
work is to design and study candidate DNA-vaccines against
melanoma pMEL-TCI-A0201 and pMEL-TCI in vitro and ex vivo.
Using original software we designed two T-cell immunogens
MEL-TCI-A0201 and MEL-TCI which are candidate DNA-vaccines
against melanoma. The first allele-specific immunogen MEL-
TCI-A0201 comprises CTL-epitopes restricted by only one allelic
variant HLA-A*0201 that is prevailing in global population. The
second universal immunogen MEL-TCI comprises CTL-epitopes
restricted by 12 major allelic variants of HLA class I molecules.
Furthermore, DNA-construct pcDNA-mart1 carrying full-length
variant of antigen MART-1 was designed. This construct was used
as a positive control. Genes encoding target immunogens have
been synthesized and cloned into vector plasmid DNA3.1 (Ant-
onets et al., 2010, Bazhan et al., 2010). Evidence of the target genes
expression in vitro after transfection of 293T-cells with obtained
DNA-vaccine constructs p MEL-TCI and pMEL-TCI-A0201 were
evaluated using three methods: reverse transcription-PCR to
determine specific polyepitope immunogen mRNA; western
immunoblotting assay with 29F2 monoclonal antibodies to
‘‘marker” epitope at the C-terminus of the polyepitope constructs;
flow cytometry assay of stained 293T cells transfected with
obtained plasmids using FITC-labeled 29F2 monoclonal antibod-
ies. It was shown that all obtained plasmids were provided
expression of target genes in eukaryotic cells.
Plasmids pMEL-TCI and pMEL-TCI-A0201 were used for trans-
fection of human monocyte derived dendritic cells to estimate
capacity of polyepitope constructs to induce specific T-cell
immune response by IFNc ELISpot analysis ex vivo. The study
was carried out in collaboration with researchers from laboratory
of molecular immunology at Scientific Research Institute of Clin-
ical immunology, Siberian Branch, Russian Academy of Medical
Sciences. License for conducting the study was approved by the
local ethic committee at this institute. Cell culture of human mel-
anoma Mel Is (HLA-A*0201+, MART-1+) was kindly provided by N.
N. Blokhin Russian Cancer Research Center (RAMS) and was used
as target cells. Monocyte suspension and suspension of
co-incubated monocytes with dendritic cells transfected with
vector plasmid DNA3.1 were used as negative controls.
Co-incubated monocytes with dendritic cells transfected with
plasmid pcDNA-mart1, encoding full-length melanoma antigen
MART-1, were used as positive control. It was shown that in the
presence of melanoma cell lysates co-incubated with monocytes
and dendritic cells transfected with plasmids pMEL-TCI-A0201
and pcDNA-mart1 (positive control) reliably more IFNc-
producing cells are detected compared with negative control
samples in the presence of lysate of melanoma cells.
Thus, it was shown that obtained plasmids pMEL-TCI-A0201,
pMEL-TCI, and pcDNA-mart1 are able to provide expression of
target proteins in eukaryotic cells. Moreover using IFNc ELISpot
assay we demonstrated that DNA vaccine pMEL-TCI-A0201
induced T-cell immune response against human melanoma anti-
gens and its efficiency is equal to full-length melanoma antigen
MART-1.
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Over time, study of malignant tumours was concentrated on
cancer cells only. Now, however, an important role of cancer cell
microenvironment and interactions cell with extracellular matrix
(ECM) is becoming evident. Tumour cells modify normal ECM to
cancer-associated matrix (CAM) thereby creating favorable condi-
tions for the growth and development of tumors. One of the main
cellular components of ECM are fibroblasts that synthesise
extracellular matrix components including proteoglycans (PG) –
complex glycosylated molecules consisting of core protein and
one or more carbohydrate chains of glycosaminoglycans. PGs
are expressed on the cell surface and in extracellular matrix for
all mammalian cells and tissues, playing an important role in
cell–cell and cell–matrix interactions and signaling.
We have hypothesised that proteoglycans are related to trans-
formation of normal ECM to cancer-associated matrix under the
influence of prostate cancer cells, and understanding of the
mechanism this transformation is very important issue. Thus,
the aim of our work was to investigate a possible involvement
of proteoglycans in the transformation normal fibroblasts to
cancer-associated fibroblasts (CAFs). To study this problem, we
co-cultivated fibroblasts with normal prostate cells (PNT2) and
prostate cancer cells with different physiological characteristics
(LNCaP, PC3, DU145) with subsequent separation of the cells and
proteoglycans expression analysis.
Firstly, we co-cultivated human fibroblasts with normal pros-
tate epithelial cell PNT2. Expression patterns of main proteogly-
cans (syndecan-1, glypican-1, perlecan, aggrecan, versican,
decorin, lumican, CSPG4/NG2, brevican) were determined in
fibroblasts before and after co-culture with PNT2 cells using RT-
PCR analysis. It was shown that after co-culture the total level
of proteoglycans expression in fibroblasts was reduced by
2-fold, although the fibroblasts expressed a similar set of proteo-
glycans with the exception of CSPG4/NG2 (which was completely
disappeared). The results suggest that normal prostate cells PNT2
affect composition and transcriptional activity of proteoglycans
in PNT2-exposed fibroblasts compared with fibroblast monocul-
ture, and this is a normal process of mutual adaptation of these
cells to each other.
At the next step, fibroblasts were co- cultivated with prostate
cancer cells of various rate of aggressiveness (hormone-
dependent non-metastatic LNCaP cells, hormone-independent
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metastatic PC3 and DU145 cells). Co-culture fibroblasts with
LNCaP cells resulted in significant down-regulation of expression
of glypican-1 and up-regulation of CSPG4/NG2 expression in the
fibroblasts, changing overall proteoglycans expression pattern in
the cells. Interestingly, CSPG4/NG2 expression is more character-
istic for nerve cells and cancer stem cells, and up-regulation of
the gene in the cancer cell-exposed fibroblasts may argue for their
dedifferentiation. Co-culture fibroblasts with more aggressive
DU145 and PC3 resulted in similar results with an additional
down-regulation of versican expression. This data show, that
prostate cancer cells affect normal fibroblasts by the other way
than normal prostate cells and stimulate them to express another
set of proteoglycans, which usually are expressed in poor-
differentiated or morphologically different cells. Data obtained
by immunocytochemical analysis confirmed RT-PCR data and
showed specific activation of some proteoglycans at the region
of contact between fibroblasts and normal but not cancer prostate
cells in co-culture. Taken together, obtained results show that
normal prostate epithelial cells affect surrounding fibroblasts
and modify transcriptional activities of proteoglycan-coding
genes in the cells, while cancer cells change the proteoglycans
expression in cancer cells-exposed fibroblasts seems contributing
to reprogramming of normal fibroblasts to CAFs. Understanding
the mechanisms of this reprogramming may help to develop a
new approach for cancer therapy based on the return reprogram-
ming of CAFs to normal fibroblasts and correction of tumour
microenvironment.
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Ability of Streptococcus pyogenes to fight cancer was discovered
and clinically tested more than 100 years ago (Coley, 1897), but the
mechanisms of these effects are unknown. Recently several
murine models demonstrating the anti-cancer activity of Group
A Streptococcus (GAS) M49 were established (Maletzki, 2008).
The present study is devoted to investigation of anti-cancer
activity of GAS M39 strains.
Materials and Methods: Tumor cells were injected subcuta-
neously in concentration of 200,000 cells per animal. Two solid
tumor models were used: hepatoma 22a in C3HA mice and
sarcoma 37 in Swiss mice. GAS (wild and mutant strains) were
injected into the tumor 2  104 per animal twice with a
5-day-interval. The influence of GAS on tumor growth was
evaluated by measurement of tumor diameter and animal
survival. Inactivation of M protein (emm) gene was generated by
insertional mutagenesis after cloning the fragment of the emm
gene in suicidal plasmid pT7ermB.The plasmid was introduced
into GAS by electroporation. Insertion had been proved by DNA
sequencing.
Results: Intratumoral injections of wild GAS M39 strain did not
influence on tumor size in mice bearing hepatoma 22a and sar-
coma 37. The second injection of GAS enhanced inhibition of
the tumor growth, but increased the death rates. The treatment
by emm mutant strain caused the inhibition of tumor growth
and showed less mortality rate both tumor models. The average
number of completely cured animals was 10%.
Conclusion: Inactivation of emm gene in GAS M39 strain
resulted in increased anti-tumor activity and decreased lethality
rate. We hypothesized that the absence of anti-phagocytic M
protein may increase phagocytosis of GAS by macrophages and
thus enhance their antitumor activity.
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Background: Microvesicles release by neoplastic cells were
found in blood and carrying a large number of tumor distinctive
molecules, like miRNA/mRNA, proteins. Considering extensive
surface of blood cells we wonder if exosomesare circulated exclu-
sively in plasma or could be associated with surface of blood cells.
Materials and Methods: Microvesicles circulating in blood of
healthy women (HW) and breast cancer patients (BCP) were stud-
ied. Blood was fractionated into plasma and cellular fractions; in
order to release cell surface bound material, blood cells were
treated as it was described for cell-surface-bound (CSB) cirDNA
(Tamkovich, 2005).Exosomes were pelleted at 100,000 g from
0.1 lm filtered supernatants obtained by plasma and CSB eluates
centrifugation at 17,000 g, resuspended in PBS and stored in
aliquots at 80 C. Size distribution of the microparticles was
characterized by TEM (Jeol, Japan), anti CD-63, CD-24, CD-9 anti-
bodies (BD Biosciences, USA) were used as exosome markers, pro-
tein concentration was measured by NanoOrange Protein
Quantitation kit (Molecular Probes, USA), total RNA and miRNA
were isolated by mirVana kit, 28S rRNA were quantified by
RT-qPCR after reverse transcription with 6-mer random primers,
miRNA using TaqMan Small RNA Assays kit (Applied Biosystems,
USA). DNA was isolated using ‘‘DNA Isolation Kit” (BioSilicaLtd,
Russia) and measured by TaqMan multiplex real-time PCR for
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